News
Phathom Pharmaceuticals Provides Clinical Trial Status Update
First New Patients Randomized in PHALCON-EE and PHALCON-HP Trials Since Temporary Pause Announced in MarchFLORHAM PARK, N.J., June 15, 2020 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc…
Share
PRA Enhances COVID-19 Monitoring Program with Integration of Microsoft Healthcare Bot Service
RALEIGH, N.C., June 12, 2020 (GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the enhancement of its commercial Health Harmony COVID-19 Monitoring Program with…
Share
CytoDyn Reached Its Enrollment Target for Phase 2 COVID-19 Trial for Mild to Moderate Indication – Primary End Point Announcement Is Next
VANCOUVER, Washington, June 11, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5…
Share
RedHill Biopharma Submits COVID-19 Clinical Trial Application for Phase 2/3 Study with Opaganib
The multi-center, randomized, double-blind, parallel-arm, placebo-controlled Phase 2/3 clinical study of opaganib for severe COVID-19 patients is planned to be conducted in Russia and…
Share
Drs. Pourhassan and Kelly of CytoDyn to Hold Conference Call to Provide Updates on COVID-19 Phase 2 and 3 Trials, NASH, BLA for HIV and Manufacturing of Leronlimab in 2020-2021
VANCOUVER, Washington, June 09, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5…
Share
Novavax President of R&D Dr. Gregory Glenn to Discuss the Development of COVID-19 Vaccines on Panel at 2020 BIO Digital
GAITHERSBURG, Md., June 08, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases…
Share
Cytokinetics to Participate In Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif.,, June 08, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is…
Share
New Book Surveys Biotechnology Thought-Leaders on COVID-19
Free worldwide in the Amazon Kindle store June 8-12 NEW YORK, June 08, 2020 (GLOBE NEWSWIRE) — RosettaBooks announced today the publication of Biotechnology in the Time of COVID-19…
Share
Constellation Pharmaceuticals Announces Appointment of Dr. Jeffrey Humphrey as Chief Medical Officer
CAMBRIDGE, Mass., June 08, 2020 (GLOBE NEWSWIRE) — Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop…
Share
Onconova Therapeutics Announces Presentation at BIO Digital 2020
NEWTOWN, Pa., June 08, 2020 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to…
Share